Palliative Care Research
Online ISSN : 1880-5302
ISSN-L : 1880-5302
Short Communications
Current Use of Sedatives for Terminal Cancer Patients near Death Receiving Home Palliative Care, and Influence on Home Care Period
Kotaro HashimotoKazuki SatoMitsuharu SasakiHiroaki TakabayashiMasanori KawaharaMasao Suzuki
Author information
JOURNAL FREE ACCESS FULL-TEXT HTML
Supplementary material

2019 Volume 14 Issue 3 Pages 187-192

Details
Abstract

Objective: This study investigated the association between use of sedatives in terminal cancer patients near death who were receiving home care and the home care period. Methods: We conducted a retrospective review of the medical records for 1032 cancer patients who received home palliative care from 17 specialized home care clinics between June and November 2013. We checked the use of sedatives within 48 hours before death at home, and we compared the home care period between patients with and without sedation. Results: The sedatives used were diazepam (n, %: 100, 52%), flunitrazepam (29, 15%), bromazepam (27, 14%), midazolam (26, 13%), and phenobarbital (20, 10%). The median home care period (median [quartiles]) was 26 [13, 63] days and 25 [10, 64] days (Adj p=0.79) for the patients with and without sedatives, respectively. Conclusion: Among terminal cancer patients near death receiving home care, 24% were administered sedatives, with more than half of those patients receiving diazepam. There was no association between use of sedatives and the home care period.

Content from these authors
© 2019 by Japanese Society for Palliative Medicine
Previous article Next article
feedback
Top